Revenue
$1.22B
Fiscal year ended 2026-06-30Operating income
$251.89M
Fiscal year ended 2026-06-30Free cash flow
$263.22M
Fiscal year ended 2026-06-30BIO-TECHNE Corp (TECH) reported revenue of $1.22B for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from BIO-TECHNE Corp’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Biological Products, (No Diagnostic Substances).
Income
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.22B | $1.22B | $1.16B | $1.14B | $1.11B | $931.03M | $738.69M | $714.01M | $642.99M | $563.00M |
| Cost of revenue | $415.97M | $429.36M | $389.34M | $366.89M | $349.10M | $298.18M | $255.50M | $240.52M | $210.85M | $188.46M |
| Gross profit | $799.07M | $790.27M | $769.72M | $769.82M | $756.50M | $632.85M | $483.19M | $473.49M | $432.14M | $374.54M |
| Operating income | $251.89M | $102.26M | $206.69M | $298.94M | $296.59M | $237.30M | $157.42M | $146.72M | $136.18M | $120.58M |
| Net income | Unavailable | $73.40M | $168.10M | $285.26M | $272.05M | $140.41M | $229.30M | $96.07M | $126.15M | $76.09M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 157.01M | shares 159.72M | shares 160.77M | shares 161.86M | shares 164.11M | shares 161.93M | shares 39.40M | shares 38.89M | shares 38.06M | shares 37.50M |
| Pretax income | $240.68M | $98.46M | $185.69M | $338.66M | $301.39M | $148.18M | $276.48M | $112.02M | $125.95M | $111.96M |
| Income tax expense | $58.82M | $25.06M | $17.58M | $53.22M | $38.29M | $8.59M | $47.18M | $15.94M | -$198.00K | $35.88M |
| Diluted EPS | $1.16 | $0.46 | $1.05 | $1.76 | $1.66 | $0.87 | $5.82 | $2.47 | $3.31 | $2.03 |
| Selling, general & administrative | $452.42M | $588.52M | $466.38M | $378.38M | $372.77M | $324.95M | $260.58M | $264.36M | $240.64M | $200.44M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $264.71M | $162.19M | $151.79M | $180.57M | $172.57M | $199.09M | $146.62M | $100.89M | $121.99M | $91.61M |
| Total assets | $2.59B | $2.56B | $2.70B | $2.64B | $2.29B | $2.26B | $2.03B | $1.88B | $1.59B | $1.56B |
| Current assets | $744.40M | $608.30M | $617.42M | $621.48M | $605.56M | $510.61M | $520.92M | $412.61M | $398.37M | $348.02M |
| Total liabilities | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Current liabilities | $163.70M | $175.85M | $159.38M | $128.51M | $176.02M | $152.28M | $106.67M | $101.98M | $79.51M | $135.52M |
| Total equity incl. NCI | $2.11B | $1.92B | $2.07B | $1.97B | $1.70B | $1.57B | $1.38B | $1.17B | $1.08B | $949.63M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $195.74M | $189.45M | $179.73M | $171.64M | $141.12M | $116.75M | $103.15M | $91.05M | $85.65M | $85.65M |
| Accounts receivable | $216.58M | $206.88M | $241.39M | $218.47M | $194.55M | $145.38M | $122.53M | $137.47M | $120.30M | $116.83M |
| Goodwill | $975.36M | $980.94M | $972.66M | $872.74M | $822.10M | $843.07M | $728.31M | $732.67M | $597.89M | $579.03M |
| Long-term debt | $200.00M | $346.00M | $319.00M | $350.00M | $243.41M | $328.83M | $344.24M | $492.66M | $339.00M | $343.77M |
| Accounts payable | $26.70M | $25.31M | $37.97M | $25.68M | $33.86M | $29.38M | $23.09M | $16.21M | $18.45M | $16.86M |
Cash flow
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $292.07M | $287.56M | $298.98M | $254.39M | $325.27M | $352.16M | $205.22M | $181.62M | $170.37M | $143.72M |
| Capital expenditures | $28.85M | $31.01M | $62.88M | $38.24M | $44.91M | $44.30M | $51.74M | $25.41M | $20.93M | $15.18M |
| Investing cash flow | -$18.19M | -$35.18M | -$203.03M | -$265.65M | -$96.85M | -$243.52M | $27.10M | -$336.80M | -$38.71M | -$305.95M |
| Financing cash flow | -$169.11M | -$253.90M | -$122.40M | $22.62M | -$242.85M | -$62.55M | -$183.80M | $134.38M | -$99.19M | $189.11M |
| Net change in cash | $102.53M | $10.40M | -$28.78M | $8.00M | -$26.52M | $52.47M | $45.74M | -$21.10M | $30.38M | $27.38M |
| Stock-based compensation | $41.36M | $40.83M | $38.04M | $39.23M | $42.18M | $48.98M | $32.37M | $32.28M | $28.24M | $14.63M |
| Common dividends paid | $49.92M | $50.39M | $50.42M | $50.28M | $50.18M | $49.62M | $48.90M | $48.36M | $47.97M | $47.32M |
| Common share repurchases | $41.68M | $275.73M | $80.04M | $19.56M | $160.95M | $43.18M | $50.11M | $15.40M | $0 | Unavailable |
| Depreciation & amortization | $97.36M | $109.90M | $111.71M | $107.24M | $101.07M | $87.75M | $82.74M | $78.17M | $64.46M | $60.04M |
Derived
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $263.22M | $256.55M | $236.10M | $216.15M | $280.36M | $307.86M | $153.47M | $156.21M | $149.43M | $128.54M |
| Gross margin | 65.8% | 64.8% | 66.4% | 67.7% | 68.4% | 68.0% | 65.4% | 66.3% | 67.2% | 66.5% |
| Operating margin | 20.7% | 8.4% | 17.8% | 26.3% | 26.8% | 25.5% | 21.3% | 20.5% | 21.2% | 21.4% |
| FCF margin | 21.7% | 21.0% | 20.4% | 19.0% | 25.4% | 33.1% | 20.8% | 21.9% | 23.2% | 22.8% |
| SBC / revenue | 3.4% | 3.3% | 3.3% | 3.5% | 3.8% | 5.3% | 4.4% | 4.5% | 4.4% | 2.6% |
| Current ratio | 4.55x | 3.46x | 3.87x | 4.84x | 3.44x | 3.35x | 4.88x | 4.05x | 5.01x | 2.57x |
| Revenue YoY growth | -0.4% | 5.2% | 2.0% | 2.8% | 18.7% | 26.0% | 3.5% | 11.0% | 14.2% | Unavailable |
| Net margin | Unavailable | Unavailable | Unavailable | 25.1% | 24.6% | 15.1% | 31.0% | 13.5% | 19.6% | 13.5% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 2.4% | 2.5% | 5.4% | 3.4% | 4.1% | 4.8% | 7.0% | 3.6% | 3.3% | 2.7% |
| Long-term debt / equity | 0.09x | 0.18x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 24.4% | 25.5% | 9.5% | 15.7% | 12.7% | 5.8% | 17.1% | 14.2% | -0.2% | 32.0% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open TECH in the interactive workspace to inspect any figure back to its filing.
Source filings
10-K · Filed 2026-08-24View SEC filing
10-Q · Filed 2026-05-06View SEC filing
10-Q · Filed 2026-02-04View SEC filing
10-Q · Filed 2025-11-05View SEC filing
10-K · Filed 2025-08-22View SEC filing
10-Q · Filed 2025-05-08View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.